HighVista Strategies LLC
Top Portfolio Positions
154 positions ·
$359,474,418 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| DBC |
Invesco DB Commodity Index Tracking Fund
|
1,057,238 | $30,607,040 | 8.51% | |
| ABVX |
Abivax S.A.
Healthcare
|
113,254 | $12,610,832 | 3.51% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
26,323 | $8,481,007 | 2.36% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
197,051 | $7,584,492 | 2.11% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
146,264 | $7,377,556 | 2.05% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
124,647 | $7,243,237 | 2.01% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
69,309 | $6,740,300 | 1.88% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
114,307 | $6,026,265 | 1.68% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
123,909 | $5,972,413 | 1.66% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
56,602 | $5,798,874 | 1.61% |
Portfolio Trend
25 quarters · across all stocks
Holdings in GHRS
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,997,760 | 213,212 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,054,654 | 240,524 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,459,084 | 241,894 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $636,890 | 52,247 | Shares | Sole | 2025-08-14 | |
| 2022-12-31 | $637,602 | 65,597 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $659,655 | 56,769 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $638,081 | 63,936 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $966,443 | 52,840 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $630,143 | 27,010 | Shares | Sole | 2022-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||